An earlier proposed 6 ng/mL cut-off value for uPAR serum level in clinics [38,39] resulted in 77% sensitivity and 55% specificity of predicting the COVID-19-induced lung damage > 25% (Figure S3). This evidence concerns the gene PLAUR and COVID-19.